Drug intelligence / Profile preview

Xiaoer Ganshu Granules

Development stage: Unknown
Administration: Oral

Overview

Xiaoer Ganshu Granules is a Traditional Chinese Medicine (TCM) in granule form, indicated for the treatment of acute upper respiratory tract infection in children. Its therapeutic actions include dispelling wind, releasing the exterior, benefiting the throat, and reducing fever. It is used to alleviate symptoms such as fever, anhidrosis or hypohidrosis, sore throat, and cough associated with exogenous cold. The formulation is derived from traditional Chinese medicine prescriptions like "Niubang Jieji Tang" and "Qingyan Ligetang". It is an approved pharmaceutical drug in China.

Other names: 小儿感冒舒颗粒

Beyond the preview

Go deeper on Xiaoer Ganshu Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoer Ganshu Granules.

Explore the full profile